Scientific article
Open access

Pharmacologie et épilepsie : un point sur les nouveaux-nouveaux antiépileptiques

Published inRevue médicale suisse, vol. 15, no. 648, p. 857-861
Publication date2019

New antiepileptic drugs are regularly approved for treatment and offer large therapeutic opportunities. Efficacy of these drugs is relatively similar on-label with different mechanisms to be combined for a synergic effect. Treatments such as cannabidiol have benefitted from large media coverage despite limited clinical evidence so far. The objective of antiepileptic drugs is to stop the recurrence of epileptic seizures with as few adverse events as possible. When confronted to a difficult-to-treat epilepsy, referral to a specialised centre is strongly advised. The aim is to confirm that the diagnosis is correct, that the treatment is well adapted (indication, pharmacokinetic and compliance) and to evaluate the indication for non-pharmacological treatments such as epilepsy surgery.

  • Anticonvulsants/therapeutic use
  • Epilepsy/complications/drug therapy
  • Humans
  • Recurrence
  • Seizures/drug therapy/etiology
Citation (ISO format)
SHEYBANI, Laurent, MERCIER, Noëlle, VULLIEMOZ, Serge. Pharmacologie et épilepsie : un point sur les nouveaux-nouveaux antiépileptiques. In: Revue médicale suisse, 2019, vol. 15, n° 648, p. 857–861.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation10/14/2019 12:18:00 PM
First validation10/14/2019 12:18:00 PM
Update time03/15/2023 6:11:31 PM
Status update03/15/2023 6:11:31 PM
Last indexation05/05/2024 3:27:21 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack